LOQUS23 THERAPEUTICS
LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease and other triplet repeat diseases.
LOQUS23 THERAPEUTICS
Industry:
Biotechnology
Founded:
2019-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.loqus23.com
Status:
Active
Total Funding:
15.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Microsoft Exchange Online Office 365 Mail
Similar Organizations
Anjarium Biosciences
Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
Dementia Discovery Fund
Dementia Discovery Fund investment in Seed Round - LOQUS23 THERAPEUTICS
Novartis Venture Fund
Novartis Venture Fund investment in Seed Round - LOQUS23 THERAPEUTICS
Dementia Discovery Fund
Dementia Discovery Fund investment in Seed Round - LOQUS23 THERAPEUTICS
SV Health Investors
SV Health Investors investment in Seed Round - LOQUS23 THERAPEUTICS
Official Site Inspections
http://www.loqus23.com
- Host name: cpweb6-premium.active-ns.com
- IP address: 84.18.203.45
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
